356 related articles for article (PubMed ID: 28645443)
1. Once- or twice-daily non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: A meta-analysis of randomized controlled trials.
Wang KL; Chiu CC; Su-Yin Tan D; Lin CY; Lai EY; Goto S; Giugliano RP; Chiang CE
J Formos Med Assoc; 2017 Aug; 116(8):591-598. PubMed ID: 28645443
[TBL] [Abstract][Full Text] [Related]
2. Appropriate doses of non-vitamin K antagonist oral anticoagulants in high-risk subgroups with atrial fibrillation: Systematic review and meta-analysis.
Kim IS; Kim HJ; Kim TH; Uhm JS; Joung B; Lee MH; Pak HN
J Cardiol; 2018 Oct; 72(4):284-291. PubMed ID: 29706404
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of reduced-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a meta-analysis of randomized controlled trials.
Wang KL; Lopes RD; Patel MR; Büller HR; Tan DS; Chiang CE; Giugliano RP
Eur Heart J; 2019 May; 40(19):1492-1500. PubMed ID: 30590440
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of nonvitamin K antagonist oral anticoagulants versus warfarin in diabetic patients with atrial fibrillation: A study-level meta-analysis of phase III randomized trials.
Patti G; Di Gioia G; Cavallari I; Nenna A
Diabetes Metab Res Rev; 2017 Mar; 33(3):. PubMed ID: 28029216
[TBL] [Abstract][Full Text] [Related]
5. Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Asians With Atrial Fibrillation: Meta-Analysis of Randomized Trials and Real-World Studies.
Xue Z; Zhang H
Stroke; 2019 Oct; 50(10):2819-2828. PubMed ID: 31422735
[TBL] [Abstract][Full Text] [Related]
6. A meta-analysis of phase III randomized controlled trials with novel oral anticoagulants in atrial fibrillation: comparisons between direct thrombin inhibitors vs. factor Xa inhibitors and different dosing regimens.
Providência R; Grove EL; Husted S; Barra S; Boveda S; Morais J
Thromb Res; 2014 Dec; 134(6):1253-64. PubMed ID: 25457584
[TBL] [Abstract][Full Text] [Related]
7. Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation Using P-gp and/or CYP450-Interacting Drugs: a Systematic Review and Meta-analysis.
Grymonprez M; Vanspranghe K; Steurbaut S; De Backer TL; Lahousse L
Cardiovasc Drugs Ther; 2023 Aug; 37(4):781-791. PubMed ID: 34637052
[TBL] [Abstract][Full Text] [Related]
8. Non-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta-analysis of randomized trials.
Xiong Q; Lau YC; Senoo K; Lane DA; Hong K; Lip GY
Eur J Heart Fail; 2015 Nov; 17(11):1192-200. PubMed ID: 26335355
[TBL] [Abstract][Full Text] [Related]
9. Standard dose versus low dose non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: A meta-analysis of contemporary randomized controlled trials.
Wang KL; Giugliano RP; Goto S; Chiu CC; Lin CY; Lai EY; Chiang CE
Heart Rhythm; 2016 Dec; 13(12):2340-2347. PubMed ID: 27614026
[TBL] [Abstract][Full Text] [Related]
10. Association of Intracranial Hemorrhage Risk With Non-Vitamin K Antagonist Oral Anticoagulant Use vs Aspirin Use: A Systematic Review and Meta-analysis.
Huang WY; Singer DE; Wu YL; Chiang CE; Weng HH; Lee M; Ovbiagele B
JAMA Neurol; 2018 Dec; 75(12):1511-1518. PubMed ID: 30105396
[TBL] [Abstract][Full Text] [Related]
11. Off-label dosing of non-vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation.
Chan YH; Chao TF; Chen SW; Lee HF; Yeh YH; Huang YC; Chang SH; Kuo CT; Lip GYH; Chen SA
Heart Rhythm; 2020 Dec; 17(12):2102-2110. PubMed ID: 32702416
[TBL] [Abstract][Full Text] [Related]
12. Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation with Coronary or Peripheral Artery Disease.
Zhang H; Xue Z; Yi D; Li X; Tan Y; Li J
Int Heart J; 2020 Mar; 61(2):231-238. PubMed ID: 32173695
[TBL] [Abstract][Full Text] [Related]
13. Low-Dose NOACs Versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Asian Patients with NVAF: A Meta-Analysis.
Li Z; Zheng Y; Li D; Wang X; Cheng S; Luo X; Wen A
Anatol J Cardiol; 2022 Jun; 26(6):424-433. PubMed ID: 35703478
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials.
Bennaghmouch N; de Veer AJWM; Bode K; Mahmoodi BK; Dewilde WJM; Lip GYH; Brueckmann M; Kleine E; Ten Berg JM
Circulation; 2018 Mar; 137(11):1117-1129. PubMed ID: 29101289
[TBL] [Abstract][Full Text] [Related]
15. Non-vitamin K antagonist oral anticoagulants have better efficacy and equivalent safety compared to warfarin in elderly patients with atrial fibrillation: A systematic review and meta-analysis.
Kim IS; Kim HJ; Kim TH; Uhm JS; Joung B; Lee MH; Pak HN
J Cardiol; 2018 Aug; 72(2):105-112. PubMed ID: 29519547
[TBL] [Abstract][Full Text] [Related]
16. Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Liver Disease: A Meta-Analysis and Systematic Review.
Fu Y; Zhu W; Zhou Y; Chen H; Yan L; He W
Am J Cardiovasc Drugs; 2020 Apr; 20(2):139-147. PubMed ID: 31485852
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation.
Renda G; Zimarino M; Ricci F; Piccini JP; Ezekowitz MD; Patel MR; Cappato R; Giugliano RP; De Caterina R
Am J Med; 2016 Oct; 129(10):1117-1123.e2. PubMed ID: 27262782
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation.
Patel SM; Braunwald E; Steffel J; Boriani G; Palazzolo MG; Antman EM; Bohula EA; Carnicelli AP; Connolly SJ; Eikelboom JW; Gencer B; Granger CB; Morrow DA; Patel MR; Wallentin L; Ruff CT; Giugliano RP;
Circulation; 2024 Mar; 149(12):932-943. PubMed ID: 38264923
[TBL] [Abstract][Full Text] [Related]
19. Non-vitamin K antagonist oral anticoagulants with amiodarone, P-glycoprotein inhibitors, or polypharmacy in patients with atrial fibrillation: Systematic review and meta-analysis.
Kim IS; Kim HJ; Yu HT; Kim TH; Uhm JS; Kim JY; Joung B; Lee MH; Pak HN
J Cardiol; 2019 Jun; 73(6):515-521. PubMed ID: 30770140
[TBL] [Abstract][Full Text] [Related]
20. Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis.
Telles-Garcia N; Dahal K; Kocherla C; Lip GYH; Reddy P; Dominic P
Int J Cardiol; 2018 Oct; 268():143-148. PubMed ID: 30041779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
